A tributyltin(IV) complex was prepared by reacting bis-tributyltin(IV) oxide with 2-{4-hydroxy-3-[(2-carboxyphenylimino)methyl]phenylazo}benzoic acid in a 1:1 metal-ligand ratio. The complex was characterized by elemental analysis, UV-Vis, IR,1H and 119Sn NMR spectroscopy and mass spectrometry techniques. The 119Sn NMR study of the complex indicated the presence of two tin centers in a similar chemical environment and the complex exhibited a five-coordinate trigonal bipyramidal geometry in the solution phase. The molecular ion peak in the EI-MS spectrum of the complex revealed its molar mass. The optimized geometry of the complex was predicted by a DFT calculation. The in vitro antifungal activity of the complex was studied against four fungal species with respect to the standard drug Amphotericin-B. A molecular docking study was also carried out to understand the mode of interaction of the complex with the active side of the enzyme present in fungal species.
No takes yet. Share an insight, caveat, or question.
Chakraborty et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: